Almirall SA PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
By Claire Milhench LONDON (Reuters) - Sovereign investors are sinking more money into tech start-ups and opening offices in Silicon Valley in the hope of bagging a...
Positive progress in Nuevolution's (ST:NUEVOL) RORγt partnership with Almirall (LON:0O9B) has triggered a €1m milestone payment (SEK10.5m) and we continue to forecast...
Nuevolution's (ST:NUEVOL) proprietary Chemetics DNA-encoded screening platform technology enables fast and accurate small molecule drug discovery. The technology has received...
The Almirall (LON:0O9B) deal announced on 12 December tops a defining year for Nuevolution AB (ST:NUEVOL); it has delivered on two key IPO promises, signing at least one licensing...
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
| Average | 12.858 (+38.706% Upside) |
| High | 18.000 |
| Low | 10.000 |
| Price | 9.270 |
| No. of Analysts | 12 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Buy | Buy | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Buy | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 154.50 | 157.38 | 147.83 | +3.68 | +2.44% | 153.13M | NASDAQ | |||
| 44.06 | 44.39 | 43.88 | -0.28 | -0.63% | 23.71M | NYSE | |||
| 5.82 | 5.99 | 5.48 | +0.20 | +3.56% | 92.80K | NASDAQ | |||
| 45.82 | 46.00 | 44.70 | +0.51 | +1.13% | 102.56K | NASDAQ | |||
| 13.81 | 14.06 | 13.545 | +0.220 | +1.62% | 149.75K | NASDAQ | |||
| 42.85 | 43.06 | 41.87 | +0.30 | +0.71% | 855.62K | NYSE | |||
| 414.36 | 424.92 | 409.05 | -6.97 | -1.65% | 715.84K | NYSE | |||
| 14.01 | 14.74 | 14.01 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 114.23 | 115.09 | 110.31 | +2.07 | +1.85% | 48.45K | NASDAQ | |||
| 103.39 | 108.78 | 102.52 | -9.52 | -8.43% | 143.31M | NASDAQ | |||
| 75.47 | 75.47 | 75.47 | +0.87 | +1.17% | 192.00 | NYSE | |||
| 44.47 | 45.77 | 44.16 | -1.79 | -3.87% | 1.09M | NASDAQ | |||
| 258.35 | 264.20 | 257.10 | -6.26 | -2.36% | 28.73M | NASDAQ | |||
| 6.55 | 6.90 | 6.11 | +0.27 | +4.30% | 36.15M | NYSE | |||
| 64.39 | 65.08 | 63.96 | +2.35 | +3.79% | 2.83K | NYSE |